Life Science AllianceImmunologyPeer-reviewed journal article
Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation
Ariful Haque AbiriD, Julia Benz, Benjamin FreyiD, Heiko BrunsiD, Gerhard KrönkeiD, Udo S. GaipliD, Kilian SchoberiD, Dimitrios MougiakakosiD, Dirk MielenziD
Abstract
Fate decisions of T helper (Th) cells are tightly linked to their metabolic states, but precise mechanistic links remain unknown, especially in humans. Using in vitro stimulation in combination with gene editing we studied how metabolic regulation shapes human Th1 cell identity and effector function. Differentiated Th1 cells displayed elevated STAT1 phosphorylation at Tyr701 and Ser727 as well as heightened T-bet and IFN{gamma} expression, which were dampened by CRISPR/Cas9-mediated STAT1 deletion. Metabolic profiling revealed enhanced glycolytic activity in Th1 in comparison to Act.T cells, evidenced by increased extracellular acidification rate, ATP production via glycolysis, glucose uptake, lactate secretion and NADH abundance. SCENITH analysis demonstrated elevated glycolysis-dependent anabolic activity of Th1 cells. Inhibition of glycolysis reduced IFN{gamma} production and STAT1 phosphorylation independent of JAK1/2 activity, STAT1 abundance or SHP-2 activity, implicating glycolysis directly in sustaining STAT1-mediated Th1 functionality. Mechanistically, O-Glycosylation, facilitated by O-Glycosyltransferase, emerged as pivotal in modulating STAT1 activity, as evident through immunoprecipitation and Western blot analysis. Pharmaceutical O-Glycosyltransferase inhibition prevented Th1 differentiation as well as STAT1 O-glycosylation. CRISPR/Cas9 mediated mutation of the O-glycosylation sites Ser499 and Thr510 sites diminished STAT1 Ser727 phosphorylation and IFN{gamma} synthesis. Together, this study highlights glycolysis as key regulator of human Th1 cell identity and effector function, with STAT1 O-Glycosylation selectively maintaining Th1 effector capacity. This mechanism could be explored to safeguard Th1 cells in antiviral immunity and autoimmunity. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/636644v1_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@1ee58aeorg.highwire.dtl.DTLVardef@1001af6org.highwire.dtl.DTLVardef@1ea2ed7org.highwire.dtl.DTLVardef@1a943fc_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 2
- FWCI
- 0.73
- Field percentile
- top 29%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human CD8+ T-cells Require Glycolysis to Elicit Effector Function
S. E. Stimpson, J. Chen, … C. E. Mathews·bioRxiv·Feb 5, 2020
- Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy
L. Wu, K. E. R. Hollinshead, … D. R. Littman·bioRxiv·Jun 10, 2020
- The glycolytic reaction PGAM unexpectedly restrains Th17 pathogenicity and Th17-dependent autoimmunity
Chao Wang, Allon Wagner, … Vijay Kumar Kuchroo·Cell ReportsPeer-reviewed·Jun 1, 2025
- A Glycolysis-Fatty Acid Metabolic Axis Shapes Human Tfh Cell Function
Someshwar Nath Jha, Bhushan Nikam, … Nimesh Gupta·bioRxiv·Apr 3, 2026
- Modulation of glucose metabolism by 2-Deoxy-D-Glucose (2DG) promotes IL-17 producing human T cell subsets
X. Chen, L. Kozhaya, … D. Unutmaz·bioRxiv·Mar 13, 2022
- STAT1 Gain-of-Function Variants Drive Altered T Cell Prevalence, Metabolism, and Heightened IL-6 Sensitivity
S. Kaviany, T. Bartkowiak, … J. C. Rathmell·bioRxiv·Nov 10, 2021